Carlsmed Inc (CARL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -19,537 | -11,724 |
| Depreciation Amortization | 108 | 75 |
| Accounts receivable | -2,379 | -2,281 |
| Accounts payable and accrued liabilities | 832 | 943 |
| Other Working Capital | -3,697 | -3,154 |
| Other Operating Activity | 3,410 | 2,458 |
| Operating Cash Flow | $-21,263 | $-13,683 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -119 | -67 |
| Investing Cash Flow | $-119 | $-67 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 6,235 | 6,235 |
| Common Stock Issued | 27 | 23 |
| Other Financing Activity | 52,288 | 38,368 |
| Financing Cash Flow | $58,550 | $44,626 |
| Beginning Cash Position | 7,372 | 7,372 |
| End Cash Position | 44,540 | 38,248 |
| Net Cash Flow | $37,168 | $30,876 |
| Free Cash Flow | ||
| Operating Cash Flow | -21,263 | -13,683 |
| Capital Expenditure | -119 | -67 |
| Free Cash Flow | -21,382 | -13,750 |